- ASSISTANT CLINICAL PROFESSOR | Radiology
- Breast Imaging
- Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Brooklyn
- Mount Sinai St. Luke's and Mount Sinai West
- Mount Sinai Beth Israel
I interpret all aspects of breast imaging, including mammograms, ultrasounds and MRIs, as well as perform interventional breast procedures such as imaging-guided breast biopsies and preoperative localizations. In addition to my clinical work, I train radiology residents and breast imaging fellows, as well as provide lectures throughout the year.
I am currently an officer for the New York Breast Imaging Society and am a member of the American College of Radiology, Radiological Society of North America and Society of Breast Imaging.
MD, Medical University of South Carolina
University of Pittsburgh Medical Center
Fellowship, Breast & Body Image
Memorial Sloan-Kettering Cancer Center
Lee KA, Jochelson MS. Post breast conservation therapy imaging and local recurrence. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2013 Dec; 57(4).
Lee KA, Zuley ML, Chivukula M, Choksi ND, Ganott MA, Sumkin JH. Risk of malignancy when microscopic radial scars and microscopic papillomas are found at percutaneous biopsy. AJR. American journal of roentgenology 2012 Feb; 198(2).
Edavettal SC, Lee KA, Negishi M, Linhardt RJ, Liu J, Pedersen LC. Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1. The Journal of biological chemistry 2004 Jun; 279(24).
Lee KA, Fuda H, Lee YC, Negishi M, Strott CA, Pedersen LC. Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenolone and 3'-phosphoadenosine 5'-phosphate. Rationale for specificity differences between prototypical SULT2A1 and the SULT2BG1 isoforms. The Journal of biological chemistry 2003 Nov; 278(45).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Lee did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.